213 related articles for article (PubMed ID: 17373877)
1. The epidermal growth factor receptor in malignant gliomas: pathogenesis and therapeutic implications.
Nakamura JL
Expert Opin Ther Targets; 2007 Apr; 11(4):463-72. PubMed ID: 17373877
[TBL] [Abstract][Full Text] [Related]
2. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
Li B; Chang CM; Yuan M; McKenna WG; Shu HK
Cancer Res; 2003 Nov; 63(21):7443-50. PubMed ID: 14612544
[TBL] [Abstract][Full Text] [Related]
3. Targeting ErbB receptors in high-grade glioma.
Berezowska S; Schlegel J
Curr Pharm Des; 2011; 17(23):2468-87. PubMed ID: 21827413
[TBL] [Abstract][Full Text] [Related]
4. Bay846, a new irreversible small molecule inhibitor of EGFR and Her2, is highly effective against malignant brain tumor models.
Longo SL; Padalino DJ; McGillis S; Petersen K; Schirok H; Politz O; Canute GW; Post DE
Invest New Drugs; 2012 Dec; 30(6):2161-72. PubMed ID: 22203214
[TBL] [Abstract][Full Text] [Related]
5. Combination of epidermal growth factor receptor targeted therapy with radiation therapy for malignant gliomas.
Krishnan S; Rao RD; James CD; Sarkaria JN
Front Biosci; 2003 Jan; 8():e1-13. PubMed ID: 12456322
[TBL] [Abstract][Full Text] [Related]
6. Aberrant receptor signaling in human malignant gliomas: mechanisms and therapeutic implications.
Nagane M; Lin H; Cavenee WK; Huang HJ
Cancer Lett; 2001 Jan; 162 Suppl():S17-S21. PubMed ID: 11164186
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic targeting of epidermal growth factor receptor in human cancer: successes and limitations.
Wykosky J; Fenton T; Furnari F; Cavenee WK
Chin J Cancer; 2011 Jan; 30(1):5-12. PubMed ID: 21192840
[TBL] [Abstract][Full Text] [Related]
8. Effect of additional inhibition of human epidermal growth factor receptor 2 with the bispecific tyrosine kinase inhibitor AEE788 on the resistance to specific EGFR inhibition in glioma cells.
Berezowska S; Diermeier-Daucher S; Brockhoff G; Busch R; Duyster J; Grosu AL; Schlegel J
Int J Mol Med; 2010 Nov; 26(5):713-21. PubMed ID: 20878094
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms underlying effects of epidermal growth factor receptor inhibition on invasion, proliferation, and angiogenesis in experimental glioma.
Guillamo JS; de Boüard S; Valable S; Marteau L; Leuraud P; Marie Y; Poupon MF; Parienti JJ; Raymond E; Peschanski M
Clin Cancer Res; 2009 Jun; 15(11):3697-704. PubMed ID: 19435839
[TBL] [Abstract][Full Text] [Related]
10. Activation of AMP-activated kinase modulates sensitivity of glioma cells against epidermal growth factor receptor inhibition.
Hartel I; Ronellenfitsch M; Wanka C; Wolking S; Steinbach JP; Rieger J
Int J Oncol; 2016 Jul; 49(1):173-80. PubMed ID: 27121290
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy.
Uribe P; Gonzalez S
Pathol Res Pract; 2011 Jun; 207(6):337-42. PubMed ID: 21531084
[TBL] [Abstract][Full Text] [Related]
12. Molecular imaging of N-linked glycosylation suggests glycan biosynthesis is a novel target for cancer therapy.
Contessa JN; Bhojani MS; Freeze HH; Ross BD; Rehemtulla A; Lawrence TS
Clin Cancer Res; 2010 Jun; 16(12):3205-14. PubMed ID: 20413434
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic targeting of the epidermal growth factor receptor in human cancer.
Dhomen NS; Mariadason J; Tebbutt N; Scott AM
Crit Rev Oncog; 2012; 17(1):31-50. PubMed ID: 22471663
[TBL] [Abstract][Full Text] [Related]
14. EGFR tyrosine kinase inhibition radiosensitizes and induces apoptosis in malignant glioma and childhood ependymoma xenografts.
Geoerger B; Gaspar N; Opolon P; Morizet J; Devanz P; Lecluse Y; Valent A; Lacroix L; Grill J; Vassal G
Int J Cancer; 2008 Jul; 123(1):209-16. PubMed ID: 18386816
[TBL] [Abstract][Full Text] [Related]
15. Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody.
Harding J; Burtness B
Drugs Today (Barc); 2005 Feb; 41(2):107-27. PubMed ID: 15821783
[TBL] [Abstract][Full Text] [Related]
16. An antisense EGFR oligodeoxynucleotide enveloped in Lipofectin induces growth inhibition in human malignant gliomas in vitro.
Sugawa N; Ueda S; Nakagawa Y; Nishino H; Nosaka K; Iwashima A; Kurimoto M
J Neurooncol; 1998 Sep; 39(3):237-44. PubMed ID: 9821109
[TBL] [Abstract][Full Text] [Related]
17. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
Chen R; Cohen AL; Colman H
Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of epidermal growth factor receptor signaling protects human malignant glioma cells from hypoxia-induced cell death.
Steinbach JP; Klumpp A; Wolburg H; Weller M
Cancer Res; 2004 Mar; 64(5):1575-8. PubMed ID: 14996711
[TBL] [Abstract][Full Text] [Related]
19. The epidermal growth factor receptor as a therapeutic target in glioblastoma multiforme and other malignant neoplasms.
Loew S; Schmidt U; Unterberg A; Halatsch ME
Anticancer Agents Med Chem; 2009 Jul; 9(6):703-15. PubMed ID: 19601750
[TBL] [Abstract][Full Text] [Related]
20. Targeting epidermal growth factor receptor in solid tumors: critical evaluation of the biological importance of therapeutic monoclonal antibodies.
Gialeli Ch; Kletsas D; Mavroudis D; Kalofonos HP; Tzanakakis GN; Karamanos NK
Curr Med Chem; 2009; 16(29):3797-804. PubMed ID: 19747140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
